[SocBiN] ICCMg 2nd annoucement

[Etienne Ruppé]

[](http://www.clinicalmetagenomics.org/)  
Dear colleagues,  
We are pleased to inform you that the **final program** of the first International Conference on Clinical Metagenomics (ICCMg, Campus Biotech, Geneva, October 13-14 2016) is now available at the [conference website](http://www.clinicalmetagenomics.org/).  
We are proud to welcome **prestigious speakers** to cover the various aspects of clinical metagenomics and its applications:  
  
**NGS and bio-informatics**  
**Patrick Wincker**              *(Genoscope, Evry, France)*: Next-generation sequencing.  
**Nick Loman** *(University of Birmingham, UK)*: What's next in NGS? The Nanopore technology.  
**Aitana Lebrand** *(Swiss Institute of Bio-informatics, Geneva, Switzerland)*: Management of metagenomic data.  
  
**Clinical Metagenomics**  
**Georges Weinstock** *(Jackson Laboratory, Farmington, US)*: Probing the Medical Microbiome.  
**Marc Eloit** *(Institut Pasteur, Paris, France)*: Clinical metagenomics in immunocompromized patients.  
**Jerôme Bouquet** *(University of San Francisco, US)*: Clinical metagenomics for diagnosis of acute Infectious diseases.  
**Gilbert Greub** *(Institute of Microbiology, Lausanne, Switzerland)*: Clinical metagenomics for the discovery of new pathogens.  
**Derrick Crook** *(University of Oxford, UK)*: Inferring the antibiogram from genomes.  
**Etienne Ruppé** *(Geneva University Hospitals, Switzerland)*: Clinical metagenomics in bone and joint infections.  
**Frank Aarestrup** *(Danish Technical institute, Lyngby, Denmark)*: Clinical metagenomics in urinary-tract infection.  
**Judith Breuer** *(Faculty of Medical Sciences, London, UK)*: Detection of Mycobacterium tuberculosis directly from samples.  
  
**I****ntestinal Microbiota**  
**Dusko Ehrlich** *(Metagenopolis, Jouy-en-Josas, France)*: The intestinal microbiota and the link with diseases.  
**Eric Pamer** *(Memorial Sloan-Kettering Cancer Center, New York, US)*: Microbiota-mediated defense against intestinal infections.  
**Christopher Ford** *(Seres Therapeutics, Cambridge, US)*: Microbiome therapeutics.  
  
**Oncology**  
**Stylianos Antonarakis** *(Geneva University Hospitals, Switzerland)*: Metagenomics and tumor profiling  
**Peer Bork** *(EMBL, Heidelberg, Germany)*: Diagnostic of colon cancer using metagenomics.  
**Cynthia Sears** *(John Hopkins University, Baltimore, US)*: Using Biofilms and Metagenomics to Diagnose Colon Cancer.  
  
ICCMg will start on Thursday October 13 at 1:45pm and will end on Friday October 14 at 3:40pm. ICCMg will take place at **Campus Biotech**, which is nicely located close to the **Geneva Lake**and **easily accessible by public transportation** from the train station or airport.  
**Abstracts** are welcomed for **poster presentations**, please note the **August 31st as the deadline** for . The posters will be presented at the specific poster exhibition and open bar on Thursday evening, followed by the **conference dinner** (optional).  
  
We hope to welcome you in Geneva and are looking forward to receiving your .  
  
With best regards  
Etienne Ruppé, Enrico Zuffi and Jacques Schrenzel  
  
  
    
____________________________________  
  
ICCMg 2016  
Campus Biotech, Geneva October 13-14, 2016  
Organised by the International Society for Clinical Metagenomics  
More information at [www.clinicalmetagenomics.org](http://www.clinicalmetagenomics.org/)  
  
  

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.su.se/pipermail/socbin-at-sbc.su.se/attachments/20160805/467d6a02/attachment.html>